These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 26778657

  • 1. Synthesis of novel polybrominated benzimidazole derivatives-potential CK2 inhibitors with anticancer and proapoptotic activity.
    Łukowska-Chojnacka E, Wińska P, Wielechowska M, Poprzeczko M, Bretner M.
    Bioorg Med Chem; 2016 Feb 15; 24(4):735-41. PubMed ID: 26778657
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, in vitro antiproliferative activity and kinase profile of new benzimidazole and benzotriazole derivatives.
    Chojnacki K, Wińska P, Skierka K, Wielechowska M, Bretner M.
    Bioorg Chem; 2017 Jun 15; 72():1-10. PubMed ID: 28340404
    [Abstract] [Full Text] [Related]

  • 3. Synthesis of new analogs of benzotriazole, benzimidazole and phthalimide--potential inhibitors of human protein kinase CK2.
    Najda-Bernatowicz A, Łebska M, Orzeszko A, Kopańska K, Krzywińska E, Muszyńska G, Bretner M.
    Bioorg Med Chem; 2009 Feb 15; 17(4):1573-8. PubMed ID: 19168362
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of Novel Acyl Derivatives of 3-(4,5,6,7-Tetrabromo-1H-benzimidazol-1-yl)propan-1-ols-Intracellular TBBi-Based CK2 Inhibitors with Proapoptotic Properties.
    Chojnacki K, Wińska P, Karatsai O, Koronkiewicz M, Milner-Krawczyk M, Wielechowska M, Rędowicz MJ, Bretner M, Borowiecki P.
    Int J Mol Sci; 2021 Jun 10; 22(12):. PubMed ID: 34200807
    [Abstract] [Full Text] [Related]

  • 5. Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases.
    Chojnacki K, Wińska P, Wielechowska M, Łukowska-Chojnacka E, Tölzer C, Niefind K, Bretner M.
    Bioorg Chem; 2018 Oct 10; 80():266-275. PubMed ID: 29966873
    [Abstract] [Full Text] [Related]

  • 6. Development and exploitation of CK2 inhibitors.
    Sarno S, Ruzzene M, Frascella P, Pagano MA, Meggio F, Zambon A, Mazzorana M, Di Maira G, Lucchini V, Pinna LA.
    Mol Cell Biochem; 2005 Jun 10; 274(1-2):69-76. PubMed ID: 16335530
    [Abstract] [Full Text] [Related]

  • 7. Effect of Simultaneous Inhibition of Protein Kinase CK2 and Thymidylate Synthase in Leukemia and Breast Cancer Cells.
    Wińska P, Skierka K, Łukowska-Chojnacka E, Koronkiewicz M, Cieśla J, Bretner M.
    Anticancer Res; 2018 Aug 10; 38(8):4617-4627. PubMed ID: 30061228
    [Abstract] [Full Text] [Related]

  • 8. Synthesis of novel chiral TBBt derivatives with hydroxyl moiety. Studies on inhibition of human protein kinase CK2α and cytotoxicity properties.
    Borowiecki P, Wawro AM, Wińska P, Wielechowska M, Bretner M.
    Eur J Med Chem; 2014 Sep 12; 84():364-74. PubMed ID: 25036794
    [Abstract] [Full Text] [Related]

  • 9. Synthesis and proapoptotic properties of new casein kinase II inhibitors.
    Koronkiewicz M, Zukowska M, Chilmonczyk Z, Orzeszko A, Kazimierczuk Z.
    Acta Pol Pharm; 2010 Sep 12; 67(6):635-41. PubMed ID: 21229880
    [Abstract] [Full Text] [Related]

  • 10. Synergistic anti-leukemic effects of CK2 inhibitors and pentabromobenzylisothioureas in vitro.
    Koronkiewicz M, Chilmonczyk Z, Kazimierczuk Z.
    Anticancer Res; 2013 Nov 12; 33(11):4891-9. PubMed ID: 24222126
    [Abstract] [Full Text] [Related]

  • 11. New inhibitors of protein kinase CK2, analogues of benzimidazole and benzotriazole.
    Bretner M, Najda-Bernatowicz A, Łebska M, Muszyńska G, Kilanowicz A, Sapota A.
    Mol Cell Biochem; 2008 Sep 12; 316(1-2):87-9. PubMed ID: 18548199
    [Abstract] [Full Text] [Related]

  • 12. CK2α and CK2α' subunits differ in their sensitivity to 4,5,6,7-tetrabromo- and 4,5,6,7-tetraiodo-1H-benzimidazole derivatives.
    Janeczko M, Orzeszko A, Kazimierczuk Z, Szyszka R, Baier A.
    Eur J Med Chem; 2012 Jan 12; 47(1):345-50. PubMed ID: 22115617
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis, biological properties and structural study of new halogenated azolo[4,5-b]pyridines as inhibitors of CK2 kinase.
    Chojnacki K, Lindenblatt D, Wińska P, Wielechowska M, Toelzer C, Niefind K, Bretner M.
    Bioorg Chem; 2021 Jan 12; 106():104502. PubMed ID: 33317841
    [Abstract] [Full Text] [Related]

  • 15. Inspecting the structure-activity relationship of protein kinase CK2 inhibitors derived from tetrabromo-benzimidazole.
    Battistutta R, Mazzorana M, Sarno S, Kazimierczuk Z, Zanotti G, Pinna LA.
    Chem Biol; 2005 Nov 12; 12(11):1211-9. PubMed ID: 16298300
    [Abstract] [Full Text] [Related]

  • 16. 2-Dimethylamino-4,5,6,7-tetrabromo-1H-benzimidazole: a novel powerful and selective inhibitor of protein kinase CK2.
    Pagano MA, Meggio F, Ruzzene M, Andrzejewska M, Kazimierczuk Z, Pinna LA.
    Biochem Biophys Res Commun; 2004 Sep 03; 321(4):1040-4. PubMed ID: 15358133
    [Abstract] [Full Text] [Related]

  • 17. Tetraiodobenzimidazoles are potent inhibitors of protein kinase CK2.
    Gianoncelli A, Cozza G, Orzeszko A, Meggio F, Kazimierczuk Z, Pinna LA.
    Bioorg Med Chem; 2009 Oct 15; 17(20):7281-9. PubMed ID: 19748274
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells.
    Kaminska B, Ellert-Miklaszewska A, Oberbek A, Wisniewski P, Kaza B, Makowska M, Bretner M, Kazimierczuk Z.
    Int J Oncol; 2009 Nov 15; 35(5):1091-100. PubMed ID: 19787263
    [Abstract] [Full Text] [Related]

  • 19. Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 inhibitors.
    Martínez R, Geronimo BD, Pastor M, Zapico JM, Coderch C, Panchuk R, Skorokhyd N, Maslyk M, Ramos A, de Pascual-Teresa B.
    Molecules; 2020 Mar 25; 25(7):. PubMed ID: 32218358
    [Abstract] [Full Text] [Related]

  • 20. Design and synthesis of CK2 inhibitors.
    Makowska M, Łukowska-Chojnacka E, Wińska P, Kuś A, Bilińska-Chomik A, Bretner M.
    Mol Cell Biochem; 2011 Oct 25; 356(1-2):91-6. PubMed ID: 21750983
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.